Anthem Biosciences Ltd
Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the co… Read more
Market Cap & Net Worth: Anthem Biosciences Ltd (ANTHEM)
Anthem Biosciences Ltd (NSE:ANTHEM) has a market capitalization of $4.18 Billion (₹361.90 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #26084 globally and #1390 in its home market, demonstrating a -2.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anthem Biosciences Ltd's stock price ₹644.40 by its total outstanding shares 561609984 (561.61 Million).
Anthem Biosciences Ltd Market Cap History: 2025 to 2026
Anthem Biosciences Ltd's market capitalization history from 2025 to 2026. Data shows growth from $4.22 Billion to $4.18 Billion (0.00% CAGR).
Anthem Biosciences Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anthem Biosciences Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.23x
Anthem Biosciences Ltd's market cap is 0.23 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.94x
Anthem Biosciences Ltd's market cap is 0.94 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $4.22 Billion | $18.45 Billion | $4.51 Billion | 0.23x | 0.94x |
Competitor Companies of ANTHEM by Market Capitalization
Companies near Anthem Biosciences Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Anthem Biosciences Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Anthem Biosciences Ltd Historical Marketcap From 2025 to 2026
Between 2025 and today, Anthem Biosciences Ltd's market cap moved from $4.22 Billion to $ 4.18 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹4.18 Billion | -1.09% |
| 2025 | ₹4.22 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Anthem Biosciences Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.18 Billion USD |
| MoneyControl | $4.18 Billion USD |
| MarketWatch | $4.18 Billion USD |
| marketcap.company | $4.18 Billion USD |
| Reuters | $4.18 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.